Two flares of Still’s disease after two doses of the ChAdOx1 vaccine
Abstract We report the case of an 18-year-old male with Still’s disease for the last 3 years, in remission, who developed two flares of his disease after receiving two doses of the ChAdOX1 nCoV-19 vaccine. While the first flare was mild requiring steroid initiation and resolved rapidly, the second flare after the second dose was much severe, requiring pulse steroid and tocilizumab. We also review three reported cases of flares of Still’s disease after COVID-19 vaccination. The temporal association of the flares with both vaccine doses strengthens the association between the vaccine administration and the flare. The proposed mechanism may be due to activation of the innate immune system by the vaccine adjuvants. This review serves to inform the medical community regarding a possible role of the vaccine in producing a systemic inflammatory response. Early detection and treatment can help reduce morbidity in these cases..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Clinical rheumatology - 41(2022), 5 vom: 06. März, Seite 1591-1596 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Roongta, Rashmi [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2022 |
|---|
| doi: |
10.1007/s10067-022-06124-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC207856656X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC207856656X | ||
| 003 | DE-627 | ||
| 005 | 20230513083334.0 | ||
| 007 | tu | ||
| 008 | 221220s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10067-022-06124-z |2 doi | |
| 035 | |a (DE-627)OLC207856656X | ||
| 035 | |a (DE-He213)s10067-022-06124-z-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Roongta, Rashmi |e verfasserin |0 (orcid)0000-0001-6785-9985 |4 aut | |
| 245 | 1 | 0 | |a Two flares of Still’s disease after two doses of the ChAdOx1 vaccine |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2022 | ||
| 520 | |a Abstract We report the case of an 18-year-old male with Still’s disease for the last 3 years, in remission, who developed two flares of his disease after receiving two doses of the ChAdOX1 nCoV-19 vaccine. While the first flare was mild requiring steroid initiation and resolved rapidly, the second flare after the second dose was much severe, requiring pulse steroid and tocilizumab. We also review three reported cases of flares of Still’s disease after COVID-19 vaccination. The temporal association of the flares with both vaccine doses strengthens the association between the vaccine administration and the flare. The proposed mechanism may be due to activation of the innate immune system by the vaccine adjuvants. This review serves to inform the medical community regarding a possible role of the vaccine in producing a systemic inflammatory response. Early detection and treatment can help reduce morbidity in these cases. | ||
| 650 | 4 | |a AOSD | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Flare | |
| 650 | 4 | |a SJIA | |
| 650 | 4 | |a Vaccine | |
| 700 | 1 | |a Mondal, Sumantro |0 (orcid)0000-0003-2451-8798 |4 aut | |
| 700 | 1 | |a Haldar, Subhankar |0 (orcid)0000-0002-3047-8481 |4 aut | |
| 700 | 1 | |a Kumar, Mavidi Sunil |4 aut | |
| 700 | 1 | |a Ghosh, Alakendu |0 (orcid)0000-0002-9463-4797 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical rheumatology |d Springer International Publishing, 1982 |g 41(2022), 5 vom: 06. März, Seite 1591-1596 |w (DE-627)167914960 |w (DE-600)604755-5 |w (DE-576)024860131 |x 0770-3198 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2022 |g number:5 |g day:06 |g month:03 |g pages:1591-1596 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s10067-022-06124-z |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4277 | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2022 |e 5 |b 06 |c 03 |h 1591-1596 | ||